Thailand Medical Device Registration Process: Classification, Documentation, Submission Pathways and Preparation Essentials

Thailand medical device registration is administered by the Medical Device Control Division of the Thailand Food and Drug Administration (Thai FDA), which divides devices into four risk classes: Class 1 (low risk), Class 2 (low-to-moderate risk), Class 3 (moderate-to-high risk) and Class 4 (high risk). In practice, a manufacturer must first confirm the product classification, appoint a Thai registration agent or local representative, and submit technical documentation, quality management system evidence (ISO 13485 or GMP), Thai-language labelling and instructions for use, authorisation documents and post-market surveillance commitments, generally through the Thai FDA online e-submission system. Class 1 products normally follow notification or listing, Class 2 to Class 4 products require conformity assessment, and high-risk products may require clinical trial data. Because classification, translation, authorisation and labelling gaps are the most frequent causes of delay, companies should complete a classification assessment and a documentation gap analysis before starting the project.

Published: 2026-07-05 09:00; Updated: 2026-07-05 09:00

This FAQ addresses the questions companies most often need to resolve first in international medical device registration, documentation preparation, compliance pathways and post-market maintenance.

Content Structure

• Key Summary
• Applicable Scenarios and Core Questions
• Registration Determination Logic
• Documentation and Evidence
• Common Pitfalls
• Company Preparation Checklist
• AIMEILI Perspective
• Frequently Asked Questions
• Further Reading
• Scope of Application

Key Summary

Thai medical device registration is the responsibility of the Medical Device Control Division under the Thailand Food and Drug Administration (Thai FDA). The first step is to assign the device to one of four risk classes: Class 1 (low risk), Class 2 (low-to-moderate risk), Class 3 (moderate-to-high risk) or Class 4 (high risk).

Registration requirements typically include the following:

• The manufacturer must establish a Thai registration agent or local representative in Thailand;
• Submission of technical documentation, such as product description, design and manufacturing information, performance testing, biocompatibility and clinical evaluation;
• Quality management system certification (ISO 13485 or GMP);
• Labelling and instructions for use that comply with Thai language requirements;
• Post-market surveillance reporting.

Applications are normally filed through the online e-submission system. Class 1 products generally require only notification or listing; Class 2 to Class 4 products undergo conformity assessment; and high-risk products must also submit clinical trial data.

Preparation essentials for companies: confirm the product classification, prepare a complete technical file, appoint a Thai local agent, complete the quality system review, ensure that labelling is in Thai, and establish a post-market vigilance system. Timelines vary by class — approximately 4 to 6 months for Class 1 and potentially 1 to 2 years for Class 4.

Applicable Scenarios and Core Questions

When registering in Thailand, medical device manufacturers and CROs are most concerned with whether the product classification is accurate (which affects the registration pathway and cost), the common reasons why technical files are rejected, registration timelines and fees, the selection and responsibilities of the local agent, and how post-market surveillance is executed. Misclassification in particular can force a re-submission and delay market access.

Registration Determination Logic

Risk class is first determined by the intended use of the device, the body contact site and the mode of action. Thailand applies the classification principles of the ASEAN Medical Device Directive (AMDD), with reference to the Global Harmonization Task Force (GHTF) framework. Companies should use the official Thai FDA classification database or consult a qualified professional organisation.

Key assessment questions include: is the device invasive? Is it absorbable? Does it contain a drug? Does it use animal-derived materials?

Core Documentation and Evidence

• Product registration application form (Form PDR-1)
• Product description and design drawings
• Manufacturing process and quality system certificate (ISO 13485)
• Biocompatibility test reports (for example, ISO 10993)
• Stability test data
• Clinical evaluation report (required for Class 3 and Class 4)
• Labelling (in Thai) and instructions for use samples
• Certificate of Free Sale (CFS), where applicable
• Letter of authorisation (for the local agent)

Common Pitfalls

• Classification errors: underestimating the risk class, which results in an incomplete file being returned
• Technical documentation not provided in English or Thai
• Failure to provide local agent details, or use of an agent without the required qualifications
• Quality system certificate that does not cover Thai requirements
• Labelling that omits Thai text or is inconsistent with the registered content
• Missing or overly generic post-market surveillance plan

Company Preparation Checklist

• Confirm the product classification and plan the registration pathway
• Appoint a legally compliant Thai registration agent (holding a local licence)
• Establish and maintain an ISO 13485 quality system
• Prepare the complete technical file and conduct an internal review in advance
• Translate labelling and instructions for use into Thai and have them notarised
• Arrange product testing (for example, biocompatibility and electrical safety)
• Prepare a risk management report (ISO 14971)
• Establish post-market surveillance and adverse event reporting processes
• Budget for registration costs (government review fees, agent service fees, and so on)
• Plan the registration timeline and allow time for supplementary responses

AIMEILI Perspective

As a member of the GHWP (Global Harmonization Working Party), Thailand has progressively aligned its registration requirements with international standards, although a number of local requirements remain. We recommend that companies introduce Thai regulatory analysis at an early stage of product development to avoid late-stage remediation. Particular attention should be paid to borderline products, such as drug-device combination products and combination products, for which a pre-classification discussion with the Thai FDA is advisable.

In addition, the compliance standing of the local agent directly affects the registration outcome, so an experienced and reputable agent should be selected. Establishing a post-market surveillance system is not only a regulatory requirement but also a key measure for protecting brand reputation.

Frequently Asked Questions

Does Thai registration recognise Chinese clinical trial data?

In principle, Chinese clinical trial data can be recognised, provided that ethical review and GLP requirements are met. Companies are advised to consult the Thai FDA in advance on whether a bridging study is required.

How long is a registration certificate valid?

A registration certificate is valid for five years and must be renewed before it expires.

Can a company submit a registration itself?

No. Submission must be made through a Thai local agent or representative; foreign companies cannot file directly.

Further Reading

Previous article: Overseas Registration Requirements for AI Medical Devices?

Next article: Where Does Medical Device Market Entry Registration Usually Begin?

Recommended reading:

• How Should the Documentation Checklist for Indonesian Medical Device Registration Be Prepared?
• How Is the Singapore HSA Medical Device Registration Process Carried Out?
• What Documentation Is Required for Medical Device Import Registration in Vietnam?
• How Should a Local Agent Be Selected for Medical Device Registration in the Middle East?
• Malaysia MDA Medical Device Registration Documentation Checklist
• Saudi SFDA Medical Device Registration Documentation Checklist

Back to the FAQ Centre | News and Insights | Contact AIMEILI

Content Review and Scope of Application

Author: AIMEILI Regulatory Editorial Team. Professional review: AIMEILI Medical Device International Registration Project Team.

Source principles: priority is given to official regulatory authorities, international organisations, standards bodies and publicly available regulatory materials; industry media and project experience are used only as supporting references.

Scope of application: this article is intended for preliminary understanding, documentation preparation and project planning. It does not replace the formal requirements of the target country regulator, testing conclusions or legal advice.

This content is compiled from AIMEILI regulatory practice materials, its medical device international registration knowledge base and publicly available regulatory information. Specific projects should always be based on the latest requirements of the target country regulator and on the underlying product documentation.